Business · 23/09/2003Updated: 10/17/2026 · 1 min read
FDA Corrects Documents for New Animal Drug Applications
Summary
The Food and Drug Administration (FDA) is correcting two documents that provided notice of the approval of new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) due to errors in chemical entities and a drug sponsor's address, aimed at improving the accuracy of the Federal Register.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →